California News Observer
SEE OTHER BRANDS

The most trusted news from California

California News Observer: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on California News Observer.

Press releases published on July 14, 2025

Santé Canada étend l’approbation d’Evkeeza® (évinacumab) chez les enfants âgés d’à peine 6 mois atteints d’hypercholestérolémie familiale homozygote (HFHo)

Santé Canada étend l’approbation d’Evkeeza® (évinacumab) chez les enfants âgés d’à peine 6 mois atteints d’hypercholestérolémie familiale homozygote (HFHo)

TORONTO, 14 juill. 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ : RARE), une société biopharmaceutique spécialisée dans la mise au point et la commercialisation de nouveaux traitements contre des maladies génétiques rares et très rares, …

Golden State Welcomes John Young, CFP® of Young Global Wealth Strategies in Boulder, CO

Golden State Welcomes John Young, CFP® of Young Global Wealth Strategies in Boulder, CO

SOUTH COAST METRO, Calif., July 14, 2025 (GLOBE NEWSWIRE) -- Golden State is pleased to welcome John Young, CFP®, founder of Young Global Wealth Strategies, Inc. in Boulder, Colorado, as its newest affiliated advisor. John Young will continue operating …

Study: First Brain Fitness Tracker Validated for Aging Independently

Study: First Brain Fitness Tracker Validated for Aging Independently

SAN FRANCISCO, July 14, 2025 (GLOBE NEWSWIRE) -- A new study shows that a novel online assessment (here) provides a valid scientific measure of the cognitive abilities of older adults related to living independently. The self-administered assessment can be …

Sunrun Announces Date for Second Quarter 2025 Earnings Report

Sunrun Announces Date for Second Quarter 2025 Earnings Report

SAN FRANCISCO, July 14, 2025 (GLOBE NEWSWIRE) -- Sunrun (Nasdaq: RUN) today announced that it will issue its second quarter 2025 earnings report after the market closes on Wednesday, August 6, 2025. A conference call has been scheduled to discuss these …

Positive Interim Phase 3 Results Highlight Potential of Ovaprene®, Novel Hormone-Free Contraceptive

Positive Interim Phase 3 Results Highlight Potential of Ovaprene®, Novel Hormone-Free Contraceptive

SAN DIEGO, July 14, 2025 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a biopharmaceutical company driven by a mission to challenge the status quo, making women's health a priority, today announced positive interim safety and efficacy results …

SoFi Announces Monthly Distributions on $THTA (12.00%)

SoFi Announces Monthly Distributions on $THTA (12.00%)

NEW YORK, July 14, 2025 (GLOBE NEWSWIRE) -- SoFi, a leading provider of thematic and income ETFs, today announced monthly distributions on the SoFi Enhanced Yield ETF (THTA). Distribution as of 07/14/2025 ETF Ticker Distribution per Share Distribution Rate …

Akka Introduces Agentic AI Platform

Akka Introduces Agentic AI Platform

SAN FRANCISCO, July 14, 2025 (GLOBE NEWSWIRE) -- Akka, the leader in helping enterprises deliver distributed systems, today introduced multiple industry-first capabilities that, together, provide enterprises with a comprehensive solution to eliminate the …

Real-World Data Demonstrate a 49% Response Rate for Commercial Amtagvi® in Patients with Advanced Melanoma

Real-World Data Demonstrate a 49% Response Rate for Commercial Amtagvi® in Patients with Advanced Melanoma

61% Response Rate Observed in Third-Line or Earlier Patients SAN CARLOS, Calif., July 14, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial biotechnology company focused on innovating, developing, and delivering novel …

INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit - HIMS

INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit - HIMS

SAN DIEGO, July 14, 2025 (GLOBE NEWSWIRE) -- Robbins Geller Rudman …

MGA’s Miniverse™ Goes Mobile! New Make It Mini™ Game Brings Big Fun in Tiny Form

MGA’s Miniverse™ Goes Mobile! New Make It Mini™ Game Brings Big Fun in Tiny Form

LOS ANGELES, July 14, 2025 (GLOBE NEWSWIRE) -- MGA Studios, an independent subsidiary of MGA Entertainment (MGA), the largest privately held toy and entertainment company in the U.S., announced today the launch of MGA’s Miniverse™ mobile game, Make It Mini …

Employees seek leadership development—but access gaps may hold them back, new report finds

Employees seek leadership development—but access gaps may hold them back, new report finds

LOS ANGELES, July 14, 2025 (GLOBE NEWSWIRE) -- InStride’s newly released 2025 Talent Priorities Report reveals that employees are ready to grow into leadership roles, but employers may be overlooking what’s required to support that growth. In the national …

Deep Isolation CEO to Appear Live on Bloomberg's Open Interest July 14 at 10:15 a.m. ET

Deep Isolation CEO to Appear Live on Bloomberg's Open Interest July 14 at 10:15 a.m. ET

BERKELEY, Calif., July 14, 2025 (GLOBE NEWSWIRE) -- Deep Isolation, a leading innovator in nuclear waste disposal technology, today announced that CEO Rod Baltzer will appear live on Bloomberg’s Open Interest on Monday, July 14, at 10:15 a.m. ET. The …

Rani Therapeutics and ProGen Announce Late Breaking Presentation at ENDO 2025 Demonstrating Bioequivalence of Novel, Bispecific GLP-1/GLP-2 Receptor Agonist Delivered Orally via RaniPill Compared to Subcutaneous Delivery 

Rani Therapeutics and ProGen Announce Late Breaking Presentation at ENDO 2025 Demonstrating Bioequivalence of Novel, Bispecific GLP-1/GLP-2 Receptor Agonist Delivered Orally via RaniPill Compared to Subcutaneous Delivery 

SAN JOSE, Calif., July 14, 2025 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced that it will …

VERSES® Announces Closing of C$9,573,758 (US$7,000,331) Public Offering of Units

VERSES® Announces Closing of C$9,573,758 (US$7,000,331) Public Offering of Units

VANCOUVER, British Columbia, July 14, 2025 (GLOBE NEWSWIRE) -- VERSES AI Inc. (CBOE:VERS) (OTCQB:VRSSD) ("VERSES'' or the "Company”), a cognitive computing company specializing in next-generation intelligent software systems, is pleased to announce that it …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service